Integrated Surgical Systems Inc.


Integrated Surgical Systems Inc. (ISS) was one of the earliest companies in the field of surgical robotics, founded in 1990 in Sacramento, California. It has developed two image-directed, semiautonomous robotic products for neurological and orthopedic surgical applications.
The ROBODOC Surgical Assistant System was developed together with IBM T. J. Watson Center. A 5 degree of freedom (DOF) IBM SCARA robot (manufactured by Sankyo Seiki) was custom designed for total hip arthroplasty - THA (surgical shaping or alteration of the joint). The system consists of a robotic arm assembly and a PC-based 3-D planning station called Orthodoc.
The Orthodoc together with the Robodoc use pre-surgical images and software to first design the surgical procedure. Surgeon can precisely define the cavity in the hip bone, size and position the prosthesis before the real surgery. Robodoc cuts the patient without direct human control of the cutting tool during the procedure. The computer aided design of the surgery results in cleanly cut cavity, accuracy, precise fit of the prosthesis and long lasting hips joints compared to the traditional methods.
The more than 50 units sold had been used in 8000 arthroplasty procedures worldwide (including hip and knee) in the 90s, and almost 20 000 in the last couple of years. In 2000, formal clinical trials for US Food and Drug Administration’s (FDA) clearance began for premarket notification 510(k) . It targeted the approval for THA procedures with the use of VerSys line of cementless hip prostheses made by Zimmer (Warsaw, IN). Unfortunately, ISS did not make it to the end of the procedures (see next post). It ceased operations in mid-2005 because of lawsuits and lack of funding, and sold Robodoc assets to Novatrix Biomedical in 2007. Using those assets, Novatrix has set up Curexo Medical Co. to continue development of Robodoc Robodoc is now sold by ROBODOC, a CUREXO Technology Co.

In 1997 ISS. purchased Innovative Medical Machines Int. (MMI, Lyon, France) to acquire the NeuroMate neurosurgery system developed at the Grenoble University based on an AID industrial manipulator. The 5 DOF NeuroMate’s controller was re-designed, and used for surgical assistance for biopsy and tumor removal. In stereotatic neurosurgery, instead of pre-operative images, the NeuroMate system provided real-time 3D images to give surgeon precise location of a tumor. This was the first neurosurgical robotic device to get CE mark in Europe, and then the FDA approval in 1997 for stereotactic neurosurgical procedures. It also has an approval for neuro-endoscopic applications and for frameless stereotactic surgery in 1999.
In the first couple of years the company has installed around 20 NeuroMate systems in the United States, Europe and Japan, and the system has been used in 8000 stereotactic brain surgeries. The system and the frameless device were sold together for about $400,000.
ISS ceased operations in mid-2005 because of lawsuits and lack of funding, and it sold its Robodoc assets to Novatrix Biomedical in 2007. Using those assets, Novatrix has set up a new company called Curexo Medical to continue development of Robodoc, which is still sold in Europe, Asia, and other regions and finally received FDA approval in 2008. The NeuroMate technology was recently acquired by Schaerer Mayfield NeuroMate AG (Lyon, France), and it is currently not available on the market.
[Source: Old robodoc.com site]

Comments

Unknown said…
Thanks to sharing with this respective legal personal injury information with us. We have huge expertise in Medical practice area Defective Medical Device lawyer. Our Orange County Personal Injury lawyers take pleasure in guiding clients through challenging legal issues.
June 12, 2022 at 4:00 AM
Unow22 said…
In general, once a drug is consumed, the body begins to metabolize it by breaking apart the molecule or otherwise chemically changing the ingested substance to facilitate the process of ultimately clearing it from the body.[6] Some substances, like alcohol, require multiple steps from several enzymes to be completely metabolized. Alcohol is broken down into acetaldehyde, a toxic, cancer-causing substance, then acetate, and finally separated into water and carbon dioxide for easy removal from the body.[7] Regarding our ability to metabolize and clear substances from the body, variations amongst individuals are difficult to isolate and adjust for. It is therefore difficult to precisely determine how long a drug will stay in the body or how long a drug will available for detection in a test, although there are some general guidelines. For those worried and concerned about a drug being detectable in their body, it’s essential to understand that the only way to ensure a negative test is not to use drugs. When learning about drugs of abuse and their duration of action, one term is frequently encountered: half-life. A drug’s half-life—sometimes called elimination half-life—represents how long it takes for a drug’s concentration in the body to drop by 50%.[10 Each substance has a unique half-life determined by the balance of metabolism and excretion rates.[11] Again, these half-lives are average durations that can be greatly impacted by a number of individual factors. In terms of substance abuse, the drug’s half-life helps to determine how long the effects will last in the body but has little to do with the speed of onset (when the effects will be felt). Benzodiazepines are a good example of the distinctions between speed of onset and half-life, since they are a large group of chemically-similar drugs often sub-classified by their widely variable onsets of effects and durations of action. With these drugs, long-acting variations with long half-lives can have a rapid or intermediate onset of action and short-acting versions can also have rapid or intermediate onset of action.[12] Changing the route of administration—injecting rather than swallowing a version with an intermediate onset of action—may speed up onset, but it will not change the half-life.[13] Since drugs with long half-lives stay in the body longer, they will be detectable for a longer period with a drug screen.[14] This means a benzodiazepine with a long-half-life like Valium may, on average, be detectable longer than a drug with short half-life like Xanax.[15]
December 15, 2022 at 8:31 PM
OAKS Clinic said…
Have a look at the knee replacement before and after pictures performed by Dr. Amyn Rajani, A known Knee Specialist in Mumbai. This section includes pre-operative pictures and even post-operative Total Knee Replacement Surgery success results.
January 6, 2023 at 11:29 PM
Unow22 said…
Plus, too much niacin can lead to serious side effects, including liver damage. Because there is no evidence that niacin is a reliable way to pass test, it’s best to avoid this method. - okeyprog. Other internet home remedies that will not help you pass test and possibly mess with your internal. And here are my opinion about based on this data I recommend trade this product, and I will say few more words on my own. Once you consume cannabis, it enters your bloodstream. From there, it makes its way to the body’s soft tissues before THC metabolites settle into your fat cells. Once the fat cells are burned, those metabolites recirculate through the bloodstream until they are eventually excreted via urine and feces. The metabolites are traceable to varying degrees by drug tests in urine, saliva, blood, and hair. Unfortunately, yes. Most drug tests are not sophisticated enough to determine the cannabinoid’s source of origin.
January 23, 2023 at 5:40 AM
Post a Comment

Popular Posts